Your browser doesn't support javascript.
loading
BAY 60-6583 Enhances the Antitumor Function of Chimeric Antigen Receptor-Modified T Cells Independent of the Adenosine A2b Receptor.
Tang, Jiaxing; Zou, Yan; Li, Long; Lu, Fengping; Xu, Hongtao; Ren, Pengxuan; Bai, Fang; Niedermann, Gabriele; Zhu, Xuekai.
Afiliação
  • Tang J; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, China.
  • Zou Y; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Li L; Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China.
  • Lu F; University of Chinese Academy of Sciences, Beijing, China.
  • Xu H; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, China.
  • Ren P; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, China.
  • Bai F; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, China.
  • Niedermann G; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, China.
  • Zhu X; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, China.
Front Pharmacol ; 12: 619800, 2021.
Article em En | MEDLINE | ID: mdl-33776765

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article